MACULAR DEGENERATION, AGE RELATED

Clinical trials for MACULAR DEGENERATION, AGE RELATED explained in plain language.

Never miss a new study

Get alerted when new MACULAR DEGENERATION, AGE RELATED trials appear

Sign up with your email to follow new studies for MACULAR DEGENERATION, AGE RELATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New eye shot aims to slow blinding eye disease

Disease control Ongoing

This study is testing a new investigational eye injection called BI 771716 against an already approved treatment, pegcetacoplan, for people with geographic atrophy. Geographic atrophy is an advanced form of age-related macular degeneration that causes progressive, permanent visio…

Matched conditions: MACULAR DEGENERATION, AGE RELATED

Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

MACULAR DEGENERATION, AGE RELATED

Get alerted when new MACULAR DEGENERATION, AGE RELATED trials appear

New eye shot aims to slow blinding eye disease